Alaunos Therapeutics, Inc. (TCRT) stock
TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.72+0.06 (+3.61%)
Close on Nov 18, 2026Market cap $4.37MP/E –Yield –
Alaunos Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Alaunos Therapeutics's total assets was $1.52M at Jun 30, 2026. For fiscal 2025 it was $2.97M, up 7.7% from the year before. Over ten years it grew -32.6% a year on average. The highest annual figure on record is $153.72M in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.97M | +7.7% |
| FY2024 | Dec 31, 2024 | $2.76M | -66.7% |
| FY2023 | Dec 31, 2023 | $8.26M | -87.3% |
| FY2022 | Dec 31, 2022 | $64.94M | -31.5% |
| FY2021 | Dec 31, 2021 | $94.87M | -35.2% |
| FY2020 | Dec 31, 2020 | $146.35M | +34.1% |
| FY2019 | Dec 31, 2019 | $109.11M | +14.8% |
| FY2018 | Dec 31, 2018 | $95.05M | -10.0% |
| FY2017 | Dec 31, 2017 | $105.61M | -0.7% |
| FY2016 | Dec 31, 2016 | $106.35M | -30.8% |
| FY2015 | Dec 31, 2015 | $153.72M | +239.8% |
| FY2014 | Dec 31, 2014 | $45.24M | -37.0% |
| FY2013 | Dec 31, 2013 | $71.75M | -14.0% |
| FY2012 | Dec 31, 2012 | $83.40M | -22.9% |
| FY2011 | Dec 31, 2011 | $108.11M | +75.7% |
| FY2010 | Dec 31, 2010 | $61.52M | +23.7% |
| FY2009 | Dec 31, 2009 | $49.74M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.52M | -68.0% |
| Q1 FY2026 | Mar 31, 2026 | $1.88M | -11.2% |
| Q4 FY2025 | Dec 31, 2025 | $2.97M | +7.7% |
| Q3 FY2025 | Sep 30, 2025 | $3.72M | +4.9% |
| Q2 FY2025 | Jun 30, 2025 | $4.74M | +1.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.12M | -64.9% |
| Q4 FY2024 | Dec 31, 2024 | $2.76M | -66.7% |
| Q3 FY2024 | Sep 30, 2024 | $3.55M | -81.7% |
| Q2 FY2024 | Jun 30, 2024 | $4.68M | -83.2% |
| Q1 FY2024 | Mar 31, 2024 | $6.04M | -87.6% |
| Q4 FY2023 | Dec 31, 2023 | $8.26M | -87.3% |
| Q3 FY2023 | Sep 30, 2023 | $19.44M | -71.1% |
| Q2 FY2023 | Jun 30, 2023 | $27.93M | -62.2% |
| Q1 FY2023 | Mar 31, 2023 | $48.64M | -42.8% |
| Q4 FY2022 | Dec 31, 2022 | $64.94M | -31.5% |
| Q3 FY2022 | Sep 30, 2022 | $67.34M | -40.8% |
| Q2 FY2022 | Jun 30, 2022 | $73.93M | -30.8% |
| Q1 FY2022 | Mar 31, 2022 | $84.99M | -41.9% |
| Q4 FY2021 | Dec 31, 2021 | $94.87M | -42.8% |
| Q3 FY2021 | Sep 30, 2021 | $113.76M | -37.4% |
| Q1 FY2021 | Jun 30, 2021 | $106.77M | -46.2% |
| Q4 FY2020 | Dec 31, 2020 | $146.35M | +34.1% |
| Q3 FY2020 | Sep 30, 2020 | $165.89M | +40.6% |
| Q2 FY2020 | Jun 30, 2020 | $181.68M | +148.3% |
| Q1 FY2020 | Mar 31, 2020 | $198.28M | +137.5% |
| Q4 FY2019 | Dec 31, 2019 | $109.11M | +14.8% |
| Q3 FY2019 | Sep 30, 2019 | $117.95M | +76.6% |
| Q2 FY2019 | Jun 30, 2019 | $73.17M | -4.2% |
| Q1 FY2019 | Mar 31, 2019 | $83.50M | -4.5% |
| Q4 FY2018 | Dec 31, 2018 | $95.05M | -10.0% |
| Q3 FY2018 | Sep 30, 2018 | $66.80M | -42.7% |
| Q2 FY2018 | Jun 30, 2018 | $76.38M | -39.8% |
| Q1 FY2018 | Mar 31, 2018 | $87.46M | -7.4% |
| Q4 FY2017 | Dec 31, 2017 | $105.61M | -0.7% |
| Q3 FY2017 | Sep 30, 2017 | $116.56M | -0.5% |
| Q2 FY2017 | Jun 30, 2017 | $126.81M | -0.9% |
| Q1 FY2017 | Mar 31, 2017 | $94.49M | – |
| Q4 FY2016 | Dec 31, 2016 | $106.35M | – |
| Q3 FY2016 | Sep 30, 2016 | $117.12M | – |
| Q2 FY2016 | Jun 30, 2016 | $128.01M | – |
See a number that looks wrong?